Current Pharmacogenomics and Personalized Medicine
Title:A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation
Volume: 10 Issue: 3
Author(s): Bev J. Holmes
Affiliation:
Keywords: Communication studies, discourse analysis, genomics and business strategy, genomics and society, knowledge translation, personalized medicine, public health pharmacogenomics, social study of science and technology.
Export Options
About this article
Cite this article as:
J. Holmes Bev, A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation, Current Pharmacogenomics and Personalized Medicine 2012; 10 (3) . https://dx.doi.org/10.2174/187569212802510003
DOI https://dx.doi.org/10.2174/187569212802510003 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Translating Mismatch Repair Mechanism into Cancer Care
Current Drug Targets Implications of Nanotechnology in Healthcare
Nanoscience & Nanotechnology-Asia Pathobiology and Therapeutic Implications of Tumor Acidosis
Current Medicinal Chemistry Synthesis and Evaluation of Biological Activities of a Series of (6-substitutedbenzothiazol-2-yl)acrylamides
Medicinal Chemistry Fluorescein-Inspired Near-Infrared Chemodosimeter for Luminescence Bioimaging
Current Medicinal Chemistry Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy Therapeutic Potential of Photochemically Active Metal Complexes based on Interaction with Enzymes
Current Topics in Medicinal Chemistry Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers
Current Pharmacogenomics and Personalized Medicine PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS
Current Pharmaceutical Design Effect of Oil Extract from Microalgae (<i>Schizochytrium</i> sp.) on the Viability and Apoptosis of Human Osteosarcoma Cells
Current Pharmaceutical Biotechnology Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology Desensitization for Drug Hypersensitivity to Chemotherapy and Monoclonal Antibodies
Current Pharmaceutical Design Novel Algorithms for the Identification of Biologically Informative Chemical Diversity Metrics
Current Computer-Aided Drug Design Anticancer Metallotherapeutics in Preclinical Development
Current Medicinal Chemistry Improved Candidate Biomarker Detection Based on Mass Spectrometry Data Using the Hilbert-Huang Transform
Protein & Peptide Letters Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Overview of Base Excision Repair Biochemistry
Current Molecular Pharmacology Recent Patents in siRNA Delivery Employing Nanoparticles as Delivery Vectors
Recent Patents on DNA & Gene Sequences